Investor Meet Company - Audio Archive

Investor Meet Company will be hosting INTERNATIONAL WORKPLACE GROUP PLC - Discussion of the FY 2025 Results, at 13th Mar 2026 at 3:15pm GMT.

Supermarket Income REIT PLC (SUPR:LSE) reported a strong half-year update with net rental income of £57 million and a £2 billion property portfolio following £398 million of acquisitions at a 6.5 percent net initial yield. The portfolio maintained 100 percent occupancy and rent collection, while rent reviews delivered a 3.8 percent uplift and around 76 percent of income comes from investment grade tenants. The company reduced its EPRA cost ratio to 9.2 percent after internalising management, issued a £250 million bond at a 5.1 percent coupon, and expanded its joint venture with Blue Owl to £845 million of assets. EPRA NTA rose to 87.5 pence per share and the dividend increased to 3.1 pence, with management guiding for at least 2 percent annual dividend growth from FY27 supported by long leases and largely inflation linked rental income.

Galliford Try Holdings PLC delivered a strong investor update, reporting continued progress against its 2030 growth strategy as the group combines disciplined risk management, a high-quality order book, and a robust balance sheet to drive sustainable returns. In its latest financial results, the company highlighted revenue growth of 1.3% to £923 million in the first half, alongside a rise in divisional adjusted operating margin to 3.2% from 3.0%, with adjusted profit before tax up more than 20% to nearly £25 million. Performance was supported by strength across its core building, infrastructure and water operations, while average month-end cash increased to £190 million, underlining Galliford Try Holdings plc’s strong cash generation and financial resilience. The group’s order book rose to £4.1 billion, with 98% of current-year revenue and 80% of 2027 work already secured, providing excellent visibility. Management reiterated its target to grow revenue to more than £2.2 billion by 2030 while achieving 4% or better margins, supported by expansion in higher-margin specialist markets including water technologies, fire protection, digital infrastructure, and affordable homes. The company also emphasised its focus on selective framework-based contracts, operational discipline, and capital allocation, balancing organic investment, bolt-on acquisitions, dividends, and share buybacks. With strong exposure to long-term UK public and regulated sector spending across water, defence, education, roads and custodial markets, Galliford Try Holdings plc said trading momentum remains positive, positioning the business for further margin expansion, earnings growth and long-term shareholder value.

Pantheon Resources PLC (PANR:AIM) delivered an investor update following its AGM, outlining company performance, strategy, and operational priorities as it advances its Alaska North Slope assets toward development. Chairman Michael Spencer highlighted a renewed focus on improving investor relations, strengthening governance, and aligning management with shareholder interests while targeting the company’s long term objective of achieving commercial oil production. Management confirmed there is no immediate need to raise capital and emphasized strict cost discipline across the business. The company’s primary growth strategy is securing a farm out partner, with several energy companies currently reviewing Pantheon’s assets in the data room, particularly the large Kodiak discovery. Leadership stated that a successful partnership could accelerate appraisal and development activity, including future drilling plans, while unlocking value from the company’s broader portfolio of fields. Overall, Pantheon reiterated its commitment to disciplined capital management, advancing its resource base toward production, and delivering long term shareholder value through strategic partnerships and operational progress.

Fisher (James) & Sons PLC (FSJ:LSE) 2025 full-year investor update highlighted a pivotal year in its turnaround, with like-for-like revenue rising 4% to £377 million, underlying operating profit up 56% to £28.6 million, and operating margins improving 60 basis points to 7.6% as the group benefits from cost efficiencies, supply chain savings, and stronger execution across its core divisions. ROCE increased to 8.6%, while net debt fell to £54 million, reducing covenant leverage to 1.3x and strengthening the balance sheet for future investment. Growth was led by solid performances in defence, energy, and maritime transport, with the defence division ending the year with a £317 million order book plus additional framework agreements, providing strong revenue visibility into 2026. Management said the three-year turnaround has created a more focused, resilient platform, with further upside from self-help initiatives, innovation, new product development, and geographic expansion in markets including the US, Japan, Uruguay, and Asia-Pacific. Fisher (James) & Sons PLC reiterated its medium-term targets of 10% underlying operating margin and 15% ROCE, supported by investment in technology, talent, and commercial excellence. While the company is monitoring geopolitical risks in the Middle East, trading in 2026 has started in line with expectations. Overall, the results underline improving company performance, stronger financial results, a growing order book, and a disciplined growth strategy aimed at accelerating revenue, enhancing margins, and delivering long-term shareholder value.

Nichols PLC (NICL:AIM) delivered a strong full-year investor update, reporting double-digit operating profit growth of 10% to £31.7 million in 2025, supported by disciplined cost management, innovation, and expansion in key international markets. The soft drinks group improved profit before tax margins to over 19%, up from 18.2% in 2024, while EBITDA rose 9.6% to £33.8 million, demonstrating continued operational efficiency. Group revenue increased 1.3% (1.9% like-for-like), driven by growth in the UK packaged segment and strong international performance, particularly in Africa where like-for-like sales rose 9.4% following the transition to a higher-margin concentrate model. Nichols ended the year with a robust cash balance of £55.7 million, reinforcing its capital allocation strategy of investing in brand growth, pursuing selective M&A opportunities, and returning cash to shareholders. The company also announced a progressive dividend increase, with the total dividend rising 5.3% and a new 1.5x dividend cover policy from 2026 to enhance shareholder returns. Strategic initiatives included innovation across the Vimto portfolio, international expansion in Africa, the Middle East and Southeast Asia, and the successful launch of a £14 million SAP S/4HANA ERP system, expected to deliver operational efficiencies over the next five to six years. With a resilient £14.5 billion UK soft drinks market, growing order book opportunities, and a clear growth strategy focused on higher-margin packaged beverages, Nichols stated that 2026 trading has started in line with market expectations, positioning the group for continued revenue growth, margin expansion, and long-term shareholder value creation.

Sareum Holdings PLC (SAR:AIM) provided an investor update alongside its interim financial results for the six months ended 31 December, outlining company performance, pipeline progress, and strategic priorities. The biotechnology company continues to advance its lead programme SDC 1801, a selective TYK2 JAK1 inhibitor targeting autoimmune diseases such as psoriasis, following positive Phase 1 data demonstrating strong safety, tolerability, and pharmacokinetics supporting once daily dosing. The Phase 2 enabling toxicology programme has restarted with a new global CRO and dosing is underway, with completion expected mid 2026 and a full regulatory package targeted by year end. Sareum also confirmed progress in formulation optimisation and GMP manufacturing to support future clinical trials. The company is preparing SDC 1802, a related TYK2 JAK1 inhibitor for oncology applications including blood cancers, for potential licensing as it seeks a specialist development partner. Meanwhile SRA 737, a clinical stage CHK1 inhibitor with promising combination therapy potential in oncology, continues to be positioned for partnering opportunities following improved licensing economics and extended intellectual property protection to at least 2041. Sareum is also expanding its pipeline through a neuroscience collaboration with Receptor AI focused on brain penetrant kinase inhibitors targeting neuroinflammatory diseases such as Alzheimer’s and Parkinson’s. Financial results show controlled operating expenses and cash resources of £2.5 million as the company maintains its strategy of advancing assets to value inflection points before securing pharmaceutical partnerships. Management highlighted multiple upcoming catalysts across the portfolio and reiterated its growth strategy focused on licensing, collaboration, and maximizing shareholder value through the development of differentiated kinase inhibitor therapies.

Dotdigital Group PLC (DOTD:AIM) presented its H1 FY26 investor update highlighting solid company performance, expanding recurring revenue, and continued execution of its growth strategy across global markets. The marketing technology platform reported forward looking annual recurring revenue exceeding £81 million following recent acquisitions, supported by a three year ARR CAGR of 14% and strong cash generation. Contracted recurring revenue now represents around 84% of total revenue with approximately 90% gross margins, reinforcing the company’s high visibility revenue model and predictable financial results. Dotdigital continues to invest 12% to 14% of revenue in product development, strengthening its AI driven customer experience data platform that integrates marketing automation, data orchestration, and multi channel engagement across email, web personalisation, influencer marketing, and loyalty tools. Strategic acquisitions including Fresh Relevance, Social Snowball, and the recently completed Alia transaction expand the product suite, increase data capture capabilities, and deepen integration within the Shopify ecosystem, supporting cross sell opportunities and higher average revenue per customer. The company now serves more than 9000 brands across 150 countries, delivering over 100,000 marketing campaigns daily while maintaining strong retention rates and growing international revenue which accounts for roughly 40% of ARR. Management highlighted continued demand for AI powered personalisation, platform consolidation, and first party data capabilities as key industry tailwinds. With adjusted EBITDA margins exceeding 30% and adjusted profit before tax margins above 20%, Dotdigital remains focused on balancing profitable growth with strategic investment while leveraging its expanding product portfolio and partner ecosystem to drive long term revenue growth, margin expansion, and increased shareholder value.

Zanaga Iron Ore Company Limited (ZIOC:AIM) latest investor update outlines a transformational funding and growth strategy designed to unlock value from its world-class Zanaga iron ore project in the Republic of Congo. Management highlighted a proposed transaction with Red Rock Minerals that provides an initial $25 million to advance engineering, environmental, social and community workstreams through to a construction decision targeted for Q3 2027, while minimizing shareholder dilution versus a conventional equity raise. The company emphasized that the deal structure preserves significant upside for shareholders through retained project optionality, a 1% net sales royalty, and the potential for a further $125 million cash injection under tranche two. Zanaga presented the project as a large-scale, high-grade, long-life and low-cost iron ore asset positioned to benefit from rising demand for premium iron ore products and the green steel transition. Management also outlined the potential for substantial future EBITDA, strong cash generation, improved project economics, and long-term value creation through production, royalty income, strategic investment, or asset monetization. Overall, the presentation framed the transaction as a major de-risking milestone that supports project development, strengthens the company’s financial position, and creates a clearer pathway toward construction, future revenue growth, and enhanced shareholder returns.

Breedon Group plc (BREE:LSE) delivered a resilient 2025 investor update, demonstrating solid company performance and financial results despite challenging construction markets across the UK, Ireland, and the United States. The building materials group reported year-on-year growth in revenue and underlying EBITDA, supported by strategic acquisitions, including the integration of Landmark in the US, which expanded Breedon’s vertically integrated asphalt, aggregates, and concrete platform in the Midwest. EBITDA margins stood at 16.3%, reflecting volume declines in key markets, though underlying margins remained resilient due to £20 million of operational efficiency initiatives. The company generated record free cash flow of £133 million, improving cash conversion and reducing leverage to 1.8x net debt to EBITDA, strengthening the balance sheet and supporting a 3% dividend increase despite an 8% decline in EPS linked to higher depreciation and interest costs. While GB construction activity remained subdued, particularly in residential housing, infrastructure demand stayed stable, and the Irish market showed strong economic momentum. In the US, the Landmark acquisition and infrastructure spending supported growth, with a strong order backlog and positive outlook for asphalt volumes heading into 2026. Breedon continues to execute its “Breedon 3.0” growth strategy, focusing on expansion through disciplined M&A, operational excellence, and sustainable investment in quarries, plants, and people. With around 50% of group revenue tied to infrastructure projects, a diversified geographic footprint, and a robust order book, the company believes it is well positioned for market recovery. Management reiterated confidence in long-term revenue growth, improved margins, and returns on invested capital above 10%, while maintaining financial flexibility to pursue further acquisitions and shareholder returns.

Cleantech Lithium PLC’s (CTL:AIM) latest investor update highlights a transformational milestone in its growth strategy, with the company securing its CEOL lithium operating contract in Chile for the Laguna Verde project, providing a 40-year framework to explore, develop, produce and commercialize lithium. Management described the award as a major de-risking event that strengthens project certainty, supports the upcoming Pre-Feasibility Study (PFS), and unlocks the next stage of discussions with potential strategic partners, including automotive, battery and commodity groups. The company expects to publish its detailed PFS by month-end, outlining key project economics such as capital costs, operating costs, NPV, IRR and development assumptions. Cleantech Lithium also plans to advance environmental permitting, complete further technical work including reinjection testing, and progress a competitive partner process aimed at securing project-level funding, potential offtake agreements and long-term development support through to production. Management reiterated that Laguna Verde remains on track as a potential next lithium producer in Chile and the country’s first major Direct Lithium Extraction (DLE) project, benefiting from improving lithium market sentiment and rising sector investment. The update also confirmed plans to restart the ASX listing process to broaden investor access, increase research coverage and enhance valuation visibility. Overall, the presentation positions Cleantech Lithium as a high-potential lithium development story, with near-term catalysts including the PFS release, regulatory approvals, strategic partnership progress and further investor updates.

PensionBee Group plc (PBEE:LSE) delivered a strong 2025 investor update, reporting robust company performance and financial results driven by customer growth, scalable technology, and expanding brand awareness. The digital pension provider ended the year with £7.4 billion in assets under administration (AUA), up 27% year-on-year, alongside £51 million in annual run-rate revenue, representing 33% revenue growth. PensionBee now serves 305,000 invested customers, supported by increased marketing investment and approximately 60% UK brand awareness. The business achieved group adjusted EBITDA profitability of £1 million, while the UK segment generated £5.4 million adjusted EBITDA with a 12% margin, reflecting improved operating leverage and disciplined cost management. PensionBee’s scalable model continues to produce predictable recurring revenue, supported by strong customer retention rates of around 95% and resilient revenue margins of roughly 65 basis points. Strategically, the company is investing in technology, automation, and AI—including the rollout of its customer chatbot Bebot—to improve productivity and customer experience. International expansion also remains a priority, with PensionBee strengthening its US strategy in partnership with State Street to capture opportunities in the $1 trillion annual rollover IRA market and the $55 billion automatic rollover segment. Looking ahead, management reaffirmed its growth strategy and long-term financial targets, aiming to exceed £100 million in revenue and a 20% adjusted EBITDA margin by 2029, with ambitions to surpass £250 million in revenue and 50% margins by 2034. With a strong balance sheet and £33 million in cash, PensionBee remains well positioned to scale both its UK and US operations while delivering sustainable growth for investors.

Haydale PLC’s (HAYD:AIM) latest investor update outlines a major strategic transformation as the company shifts from an R&D-led organisation to a commercial advanced materials and clean technology business focused on monetising its proprietary HD+ plasma functionalisation technology. The company highlighted progress in productisation and commercialization, led by its graphene-enabled Just Heat energy-efficient heating systems, which have achieved commercial validation across residential, social housing, hospitality, agriculture and industrial applications. Haydale’s growth strategy is supported by the acquisition and integration of SMCC, a national sales, programme management and installer platform that provides a scalable route to market through partnerships with banks, utilities and manufacturers, enabling zero-cost customer acquisition and strong cross-selling opportunities. Management reported that contracted revenues already cover more than 100% of H1 expectations and reiterated its target to achieve positive EBITDA within 12 months, supported by a strengthened balance sheet following a £5.75m fundraise and a significant cost-base reduction during the company’s strategic reset. The business is building recurring and subscription-style revenue streams through installation frameworks, service contracts and digital energy management tools. Beyond heating, Haydale is expanding its advanced materials portfolio with graphene-enabled thermal fluids for data centre cooling and additional heating solutions such as coving and skirting products, reinforcing its focus on energy efficiency and decarbonisation markets. Overall, the update positions Haydale as a scalable clean technology platform with improving revenue visibility, diversified growth opportunities, and a clearer commercial pathway driven by product innovation, strategic partnerships, and expanding market demand for energy-efficient solutions.

Temple Bar Investment Trust PLC’s (TMPL:LSE) latest investor update highlights strong long-term company performance, with the Redwheel-managed portfolio delivering top-tier NAV and share price total returns over three and five years, supported by a disciplined value-driven growth strategy focused on attractively priced, cash-generative businesses. The presentation underscores improving financial results and shareholder returns, including a 2025 total dividend of 15p per share and a yield of around 4%, with the board targeting real dividend growth over time. Management emphasized a diversified portfolio of roughly 35 holdings, selective exposure to financials, energy, consumer staples and communications, and a contrarian approach to capital allocation—trimming sectors after strong re-ratings and adding to undervalued names where long-term earnings, free cash flow and margin recovery potential remain compelling. The trust continues to trade on a modest valuation of about 11x earnings, below both the UK market and global indices, reinforcing its appeal for investors seeking UK equity income, valuation discipline and medium-term upside. While acknowledging market volatility, macro uncertainty and stock-specific challenges in holdings such as WPP and Diageo, management reiterated confidence in the portfolio’s earnings resilience, income profile and ability to benefit from improving sentiment toward undervalued UK and international equities. Overall, Temple Bar’s investor presentation positions the trust as a credible option for income-focused investors seeking dividend growth, attractive valuation, and disciplined exposure to long-term revenue and EBITDA growth opportunities.

MediaZest PLC (MDZ:AIM) delivered a strong FY25 investor update highlighting significant improvement in company performance, financial results, and growth strategy for the year ended 30 September 2025. The creative audiovisual solutions provider reported revenue growth of 35 percent to over £4.1 million and gross profit growth of 47 percent, alongside a return to profitability with EBITDA of approximately £331,000 and net profit close to £100,000 compared with a prior year loss. The company also strengthened its balance sheet through debt restructuring, including the write off of more than £500,000 of interest and repayment of an invoice discounting facility, while ending the period with improved cash and raising additional equity funding to support expansion. Mediazest continues to build predictable recurring revenue streams through service contracts, software licensing, and maintenance agreements, with its recurring revenue run rate rising to more than £1.2 million. Operational momentum was driven by major client wins and contract expansions across retail, automotive, and corporate sectors, including a large scale rollout for First Rate Exchange Services across more than 1,200 locations with a five year support agreement, alongside ongoing work with brands such as Pets at Home, Lululemon, Arc’teryx, Hyundai, and Kia. Management expects further growth in FY26 supported by a strong order book, expanding international projects across Europe, and increasing demand for digital signage and audiovisual solutions. Looking ahead, the company is targeting revenue above £5 million and higher profitability while pursuing strategic acquisitions to add scale, diversify its client base, and capitalize on the growing global digital signage market, reinforcing its long term growth strategy and shareholder value creation.

River UK Micro Cap will broadcast its AGM live for the first time, inviting shareholders to join the session led by John Blowers, Chairman.

Costain Group PLC (COST_LSE) delivered a strong investor update alongside its full year 2025 financial results, highlighting solid company performance, improved shareholder returns, and a robust growth outlook driven by long term infrastructure investment. The engineering and construction group reported a 9 percent increase in operating profit to £47.1 million and achieved operating margins of 4.5 percent, reflecting the strength and quality of its contract portfolio and disciplined project delivery. Revenue visibility remains high with a record forward work position of £7 billion, up 30 percent year on year and representing more than six times annual revenue, providing strong confidence in near term financial results and future growth. Around 90 percent of revenue for 2026 is already secured, while a significant step change in performance is expected from 2027 as major projects in water, transportation, aviation, and nuclear infrastructure move into full delivery. Costain also strengthened its balance sheet through strong cash generation and pension scheme actions, enabling enhanced capital returns including increased dividends and the launch of a £20 million share buyback programme. Management expects normalized operating margins of around 4 percent, with a strategic ambition to reach 5 percent as productivity improvements and consultancy services growth continue. The company remains well positioned to benefit from the UK government’s long term infrastructure pipeline, which includes £725 billion of planned investment over the next decade. With a resilient contract structure designed to manage inflation and supply chain pressures, strong net cash, and disciplined risk management across long term frameworks, Costain believes its strategy focused on essential and non discretionary infrastructure investment will support sustainable revenue growth, improved margins, and continued value creation for shareholders.

Biotech Growth Trust PLC (BIOG:LSE) delivered an investor update outlining recent company performance, sector dynamics, and its growth strategy ahead of the financial year end. Managed by OrbiMed, a global healthcare investment firm with more than 25 years of experience and approximately 20 billion dollars in assets under management, the trust focuses on identifying high potential biotechnology companies through deep scientific analysis and a global research platform. Despite significant volatility across the biotechnology sector since 2021, the trust reported strong recovery momentum with net asset value growth of 69 percent year to date through February, outperforming the NASDAQ Biotechnology Index by 32 percent. Management highlighted that the previous drawdown was largely driven by macroeconomic factors including rising interest rates and political uncertainty rather than deteriorating fundamentals, creating historically attractive valuations across emerging biotech companies. The portfolio strategy emphasizes small and mid cap innovators developing first in class and best in class therapies across key therapeutic areas such as oncology and central nervous system disorders, supported by increasing FDA approvals, strong clinical innovation, and accelerating pharmaceutical industry mergers and acquisitions. Additional growth opportunities include expanding biotechnology research in China and global demand for breakthrough therapies addressing unmet medical needs. The trust continues to apply disciplined portfolio construction, managing risk around clinical milestones while maintaining targeted gearing between 5 and 10 percent. With pharmaceutical companies facing revenue pressure from patent expiries and actively acquiring biotech assets, management believes the sector is entering a new recovery phase with improving valuations, rising M and A activity, and supportive regulatory conditions, positioning Biotech Growth Trust to capture long term biotechnology innovation and deliver attractive shareholder returns.

CQS New City High Yield Fund Limited (NCYF:LSE) delivered a solid investor update alongside its latest interim financial results, reporting a net asset value (NAV) total return of 4.85% and a share price total return of 4.61% for the six months to 31 December. The investment trust continued to trade at a healthy premium to NAV of around 5–6%, enabling the issuance of over 44.5 million new shares (£22.5m) during the period, with additional issuance continuing into the new year—reflecting strong investor demand. The fund maintained its focus on delivering high and sustainable income, declaring two quarterly dividends of 1p per share, fully covered by earnings and contributing to an attractive yield of approximately 8.9%. Managed by Manulife CQS, the diversified high-yield credit portfolio combines corporate bonds, equities, and preference shares across roughly 90–110 holdings, with a weighted average duration of around 3.25 years, helping mitigate interest rate risk. Portfolio positioning remains concentrated in financials and income-generating assets, supported by rigorous credit analysis from a team of more than 25 analysts. Key holdings include companies such as Shawbrook Bank, Stonegate Pubs, Travelodge, and Barclays, contributing to stable portfolio income and capital preservation. Management highlighted ongoing market volatility driven by geopolitics, inflation, and interest rate uncertainty, but noted that higher-for-longer rates can benefit the fund by increasing yields on newly issued debt. With a disciplined growth strategy focused on diversification, risk management, and income generation, the company remains on track to achieve AIC Dividend Hero status, marking 20 consecutive years of dividend growth, reinforcing its position as a compelling high-yield income investment for long-term shareholders.

Synectics plc reported strong FY2025 financial results, delivering robust revenue growth, improved EBITDA, and a strengthened balance sheet, alongside a strategic transformation aimed at driving scalable long-term growth. For the year ended 30 November 2025, group revenue increased 22% to £68 million, supported by a major casino surveillance deployment in Southeast Asia and strong demand across transport, leisure, and critical infrastructure markets. Adjusted EBITDA rose 36% to £8.5 million, with EBITDA margins improving to 12.5%, while Synectics Systems recorded revenue growth of 21% to £43 million and Ocular Integration grew revenue 24% to £26.4 million. The company also ended the year with a record cash balance of £14.1 million, reflecting strong operating cash flow and reinforcing its debt-free financial position. Operationally, Synectics continues to expand its AI-driven security and surveillance technology, with its Synergy Detect platform receiving industry recognition for innovation. Looking ahead, management outlined a strategic repositioning toward a scalable, product-led and partner-enabled growth model, designed to enhance operating leverage and recurring revenue opportunities. The company expects FY2026 to be a transitional year, reflecting the absence of the one-off casino contract and increased strategic investment, before accelerating growth from FY2027 onward, supported by double-digit revenue growth, expanded partner distribution, and product innovation across AI, cloud, and cybersecurity capabilities. With a robust order book, growing pipeline, and progressive dividend policy, including a proposed 5p per share dividend, Synectics aims to deliver sustainable shareholder returns while strengthening its global presence in intelligent security and surveillance solutions.